Literature DB >> 1928249

Marked intraocular pressure response to instillation of corticosteroids in children.

M Ohji1, S Kinoshita, E Ohmi, Y Kuwayama.   

Abstract

We examined intraocular pressures of patients with strabismus whose eyes were instilled with corticosteroid eyedrops after a strabismus operation. Group A consisted of 11 children under 10 years of age whose eyes were instilled with 0.1% dexamethasone; Group B consisted of nine patients 10 years old or older whose eyes were instilled with 0.1% dexamethasone; and Group C consisted of 13 children under 10 years of age whose eyes were instilled with 0.1% fluorometholone. In Group A, four patients had intraocular pressures greater than 30 mm Hg, five had intraocular pressures from 21 to 30 mm Hg, and two had intraocular pressures under 21 mm Hg one or two weeks postoperatively. The intraocular pressure decreased to less than 21 mm Hg one week after discontinuation of dexamethasone treatment in all nine patients. No patients in Groups B or C had intraocular pressures greater than 20 mm Hg. Our results suggest that marked ocular hypertensive response to 0.1% dexamethasone treatment occurs frequently in children under 10 years of age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928249     DOI: 10.1016/s0002-9394(14)76256-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 3.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery.

Authors:  M Wright; Z Butt; G McIlwaine; B Fleck
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

5.  Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.

Authors:  Timothy L Comstock; Michael R Paterno; Kirk M Bateman; Heleen H Decory; Matthew Gearinger
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

6.  Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone.

Authors:  Kazuyuki Hirooka; Fumio Shiraga; Shigeto Tanaka; Tetsuya Baba; Hiroshi Mandai
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

7.  Ocular hypertensive response to topical dexamethasone ointment in children.

Authors:  Yoon Jung Lee; Chan Yi Park; Kyung In Woo
Journal:  Korean J Ophthalmol       Date:  2006-09

8.  The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.

Authors:  Srishti Kothari; C Stephen Foster; Maxwell Pistilli; Teresa L Liesegang; Ebenezer Daniel; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Scott D Lawrence; John H Kempen
Journal:  Ophthalmology       Date:  2015-07-30       Impact factor: 12.079

Review 9.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

10.  Effect of Topical Brimonidine 0.15% on Conjunctival Injection after Strabismus Surgery in Children.

Authors:  Dong Hyun Kim; Hee Kyung Yang; Sang Beom Han; Jeong-Min Hwang
Journal:  J Ophthalmol       Date:  2021-05-04       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.